/viestories/media/media_files/2026/01/07/futurecure-health-raises-104-cr-in-series-c-round-led-by-carnelian-asset-management-2026-01-07-08-51-58.png)
FutureCure Health, a healthcare technology company, has secured INR 104 crore ( around $11 mn ) in its Series C funding round led by Carnelian Asset Management LLP, with participation from other investors.
The funding comes after a previous $4 million round in 2022 which was backed by Kotak Alternate Asset Management, RVCF Ventures and Unicorn India Ventures.
The company plans to use the funds to grow its clinic network, improve its digital platforms, and explore technology-based care models for other long-term lifestyle diseases.
Read also- Voice AI firm Arrowhead raises $3 million in seed round
“This funding has reinforced our conviction that globally relevant healthcare technologies can be built in India. As we scale NeuroEquilibrium across hospitals in India and globally and expand into chronic lifestyle diseases such as migraine and diabetes, our focus is on using technology to bridge the shortage of specialist doctors. Precise, scalable diagnostics can democratise super-speciality healthcare and act as a true force multiplier for better outcomes,” said Rajneesh Bhandari, Founder, FutureCure Health.
Dr Anita Bhandari, Founder, FutureCure Health, said, “Vertigo/dizziness is often misdiagnosed, leaving patients untreated for years. Our work with 150,000+ patients proves that accurate diagnosis changes outcomes. This funding will help us take specialised vertigo care global.”
About FutureCure Health
Founded in 2015 by Rajneesh Bhandari and Anita Bhandari, FutureCure runs NeuroEquilibrium, its fully owned subsidiary that operates a chain of clinics for diagnosing and treating vertigo and dizziness. Unlike traditional methods that mainly provide short-term relief, NeuroEquilibrium aims to find the exact cause of vertigo—whether it comes from the inner ear, the brain, or balance systems—so patients receive the right treatment.
NeuroEquilibrium helps solve the global shortage of specialised vertigo care. It uses advanced diagnostic tools, cloud-based remote systems, and deep technology to deliver accurate treatment beyond major cities, reaching patients around the world.
/viestories/media/media_files/2025/08/07/gift_ads_01-2025-08-07-16-54-28.jpg)
As NeuroEquilibrium expands across hospitals in India and other countries, and moves into chronic lifestyle conditions like migraine and diabetes, it uses technology to reduce dependence on specialist doctors. Its scalable and accurate diagnostic approach helps make specialised healthcare more accessible and effective.
The company works closely with hospitals, ENT clinics, and neurology centres. It says it operates more than 300 clinics across India and 16 other countries, and has helped diagnose and treat over 150,000 patients, leading to better long-term health outcomes.
Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:
Latest Business and Startup News: Discover Funding Trends and Stories Shaping Indian Startups.
Startup Funding News: Your Gateway to Every Funding Update.
Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.
Startup Stories: Discover inspiring tales of startups overcoming challenges, and achieving success.
